Filing Flows › Healthcare Triangle (HCTI) › R&D spending
Healthcare Triangle (HCTI) R&D spending by quarter
Healthcare Triangle's R&D spending was $51K in Q2 2026 (second quarter 2026), -40% from Q1 2026. Over the last 6 quarters it ranged from $51K (Q2 2026) to $279K (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $51K | -40% | -7% |
| Q1 2026 | $85K | -70% | -41% |
| Q4 2025 | $279K | +373% | — |
| Q3 2025 | $59K | +7% | — |
| Q2 2025 | $55K | -62% | — |
| Q1 2025 | $144K | — | — |
Q2 2026 at a glance
Healthcare Triangle, Q2 2026: revenue $9.2M (+158% year over year), operating margin -44.3%, net loss $4.4M, operating cash flow −$833K. The chart follows the revenue to costs, profit and cash.
Questions
What is Healthcare Triangle's R&D spending?
Healthcare Triangle's R&D spending was $51K in Q2 2026 (second quarter 2026), -40% from Q1 2026.
How has Healthcare Triangle's R&D spending changed?
Over the last 6 quarters it ranged from $51K (Q2 2026) to $279K (Q4 2025).